Antigen-binding molecule comprising altered antibody variable region binding CD3 and CD137

TW202627249APending Publication Date: 2026-07-01CHUGAI PHARMA CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW115109864
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2017-12-05
Filing Date
2018-12-04
Publication Date
2026-07-01
Patent Text Reader

Abstract

Antigen-binding domains that are capable of binding to CD3 and CD137 but do not bind to CD3 and CD137 at the same time and methods of using the same are provided. Methods to obtain antigen binding domains which bind to two or more different antigens more efficiently are also provided.
Need to check novelty before this filing date? Find Prior Art